Medicine & Life Sciences
Phosphatidylinositol 3-Kinase
100%
Breast Neoplasms
83%
Neoplasms
80%
PLX8394
73%
Alpelisib
59%
Clinical Trials
51%
Granulosa Cell Tumor
47%
Genome
44%
Activins
44%
Artificial Intelligence
43%
Physicians
41%
Mechanistic Target of Rapamycin Complex 1
41%
Triple Negative Breast Neoplasms
39%
Pandemics
34%
Adjuvant Chemotherapy
33%
Genomics
33%
Phosphatidylinositol 3-Kinases
32%
Mutation
32%
ErbB Receptors
31%
Estrogen Receptors
30%
Ovarian Neoplasms
29%
Therapeutics
28%
MEHD7945A
26%
Lung Neoplasms
26%
Registries
25%
Hormones
23%
activin A
22%
Resuscitation Orders
21%
Neoplasm Metastasis
20%
Growth Differentiation Factor 2
18%
Non-Small Cell Lung Carcinoma
17%
Language
17%
Proxy
15%
Drug Resistance
15%
Industrial Development
15%
Cachexia
13%
Knowledge Bases
13%
2-(4-chlorophenyl)-1-(4-(7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one
13%
Walk Test
13%
Phosphotransferases
12%
Alleles
12%
Amino Acids
11%
Phosphorylation
11%
Genetic Phenomena
11%
Neuregulin-1
10%
Standard of Care
10%
Pharmaceutical Preparations
10%
Drug Development
10%